Author

E. P. Ricci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Assay:bulk RNA-seq· 2 Assay:proteomics· 2 Approach:biophysical modeling· 1 Research Focus:cell signaling & trafficking· 1 Assay:CRISPR screen· 1

Frequent Co-Authors

E. Labaronne· 3 shared A. Corbin· 2 shared A. L. Chaves Valadao· 2 shared A. Rebendenne· 2 shared C. Goujon· 2 shared F. Aube· 2 shared F. Garcia de Gracia· 2 shared J. McKellar· 2 shared

Activity by Year

2017-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

E. Labaronne

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Human MX1 orchestrates the cytoplasmic sequestration of neo-synthesized influenza A virus vRNPs

J. McKellar, F. Garcia de Gracia, C. Aube, A. L. Chaves Valadao, M. Tauziet, M. Arnaud-Arnould, A. Rebendenne, A. Neyret, E. Labaronne, E. P. Ricci, B. Delaval, R. Gaudin, N. Naffakh, S. Gallois-Montbrun, O. Moncorge, C. Goujon

This study shows human MX1 restricts influenza A virus by sequestering vRNPs in cytoplasmic clusters via dynein and microtubules, reducing viral production.

bioRxiv · Feb 22, 2024 · PreprintMicrobiology

Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair

F. Aube, N. Fontrodona, L. Guiguettaz, E. Vallin, A. Lapendry, E. P. Ricci, D. Auboeuf

This study shows that MAPK inhibitors reduce aspartate and glutamate in melanoma cells, leading to DNA repair defects and increased mutations through metabolic adaptation.

bioRxiv · Jun 19, 2023Cancer Biology

Stable Structures or poly(A)-binding protein loading protect cellular and viral RNAs against ISG20-mediated decay

C. Louvat, S. Deymier, X.-N. Nguyen, E. Labaronne, K. Noy, M. Cariou, A. Corbin, M. Mateo, E. P. Ricci, F. Fiorini, A. Cimarelli

The paper identifies PABP1 loading and terminal stem-loop structures as factors protecting RNAs from ISG20-mediated decay, with implications for both cellular and viral RNAs.

bioRxiv · Jun 5, 2023 · PreprintMicrobiology

The DEAD box RNA helicase DDX42 is an intrinsic inhibitor of positive-strand RNA viruses

B. Bonaventure, A. Rebendenne, F. Garcia de Gracia, J. McKellar, S. Gracias, E. Labaronne, M. Tauziet, A. L. Chaves Valadao, E. Bernard, L. Briant, N. Gros, W. Djilli, M. Arnaud-Arnould, V. Courgnaud, H. Parrinello, , C. Goujon

This study identifies DDX42 as an intrinsic antiviral inhibitor that restricts HIV-1 and other positive-strand RNA viruses but not negative-strand RNA viruses.

bioRxiv · Oct 28, 2020Microbiology

Efficient genome editing in primary cells and in vivo using viral-derived "Nanoblades" loaded with Cas9/sgRNA ribonucleoproteins

P. E. Mangeot, V. Rissons, F. Fusil, A. Marnef, E. Laurent, J. Blin, V. Mournetas, E. Massourides, T. J. M. Sohier, A. Corbin, F. Aube, C. Pinset, L. Schaeffer, G. Legube, F.-L. Cosset, , E. P. Ricci

bioRxiv · Oct 12, 2017Cell Biology